Novartis gets approval to sell Kymriah in Japan for $306,000

A Japanese government panel approved on Wednesday a price of 33.5 million yen ($305,800) for Novartis' cancer treatment Kymriah, allowing the Swiss drugmaker to press ahead with a campaign to kick-start sluggish sales of the treatment.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news